GenAI is changing pharma operations. Explore real-world tools and use cases for AI in pharmaceutical industry workflows.

Sanofi announced it is punting more than $9 billion to acquire Blueprint Medicines and its Ayvakit, BLU-808 and immunology ...

The American Society for Clinical Oncology’s Annual Meeting for 2025 is, if nothing else, absolutely overwhelming and ...

In 2018, the FDA began an investigation into nitrosamine impurities in drugs that led to high-profile recalls for heartburn ...

Telesis Bio has announced a licensing agreement with Regeneron, enabling the latter to deploy the Gibson SOLA platform at R&D ...

On the 30th of last month, the Korea Pharmaceutical and Biological Association held a 'KPBMA Ethics Management Workshop' at ...

Pharmaceutical manufacturer Sigachi Industries has announced a 10 per cent final dividend for FY25 after posting a strong Q4 ...

Commissioner Martin Makary and two of his deputies aim to meet with drugmaker CEOs to discuss how the agency can “modernize” ...

The row between pharma companies and the U.K. government over rebates has intensified, with the Association of the British Pharmaceutical Industry (ABPI) calling up its members to speak on the record, ...

Pharma-Bio Serv, Inc. operates as a regulatory affairs ... food industries, and allied products companies. The company was founded in 1993 and is headquartered in Dorado, Puerto Rico.

East Midlands-based biotechnology company N4 Pharma has formed a new senior leadership team featuring consultants in drug ...